Follow
Mike Frick
Mike Frick
Treatment Action Group
Verified email at post.harvard.edu
Title
Cited by
Cited by
Year
Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV
MR O'Donnell, A Daftary, M Frick, Y Hirsch-Moverman, KR Amico, ...
The International Journal of Tuberculosis and Lung Disease 20 (4), 430-434, 2016
962016
Fighting TB stigma: we need to apply lessons learnt from HIV activism
A Daftary, M Frick, N Venkatesan, M Pai
BMJ global health 2 (4), e000515, 2017
782017
The TB vaccines pipeline: where are we going, where have we been
M Frick
Clayden P, Collins S, Daniels C, et al.; i-Base/Treatment Action Group, 2013
63*2013
2015 report on tuberculosis research funding trends, 2005–2014: a decade of data
M Frick
Treatment Action Group, 2015
53*2015
2016 report on tuberculosis research funding trends, 2005–2015: no time to lose
M Frick
Treatment Action Group, 2016
312016
Tuberculosis, human rights and ethics considerations along the route of a highly vulnerable migrant from sub-Saharan Africa to Europe
V Wild, D Jaff, NS Shah, M Frick
The International Journal of Tuberculosis and Lung Disease 21 (10), 1075-1085, 2017
282017
End stigmatizing language in tuberculosis research and practice
M Frick, D von Delft, B Kumar
Bmj 350, 2015
272015
The use of bedaquiline in regimens to treat drug-resistant and drug-susceptible tuberculosis: a perspective from tuberculosis-affected communities
LR Mingote, D Namutamba, F Apina, N Barnabas, C Contreras, T Elnour, ...
The Lancet 385 (9966), 477-479, 2015
252015
A community perspective on the inclusion of pregnant women in tuberculosis drug trials
L McKenna, M Frick, C Lee, D Namutamba, L Smit, M Theunissen, ...
Clinical Infectious Diseases 65 (8), 1383-1387, 2017
222017
Public investments in the clinical development of bedaquiline
D Gotham, L McKenna, M Frick, E Lessem
PLoS One 15 (9), e0239118, 2020
202020
Funding for tuberculosis research—an urgent crisis of political will, human rights, and global solidarity
M Frick
International Journal of Infectious Diseases 56, 21-24, 2017
192017
Falling short of the rights to health and scientific progress: inadequate TB drug research and access
M Frick, I Henry, E Lessem
Health and human rights 18 (1), 9, 2016
192016
The scientific response to TB–the other deadly global health emergency
RE Chaisson, M Frick, P Nahid
The International Journal of Tuberculosis and Lung Disease 26 (3), 186, 2022
182022
The evolving role of advocacy in tuberculosis
A DeLuca, E Lessem, D Wegener, LR Mingote, M Frick, D Von Delft
The Lancet Respiratory Medicine 2 (4), 258-259, 2014
182014
Tobacco retail clustering around schools in New York City: examining “place” and “space”
M Frick, MC Castro
Health & place 19, 15-24, 2013
182013
Activism on rifapentine pricing: removing cost barriers to improve the uptake of tuberculosis research innovations
A DeLuca, M Frick, E Lessem, J Kanouse, D Wegener, LR Mingote
Public health action 4 (4), 238-242, 2014
162014
Tuberculosis research and development: seeding the future
C Lienhardt, A Zumla, N Gebreselassie, M Frick, G Gray, T Kasaeva, ...
The Lancet Respiratory Medicine 6 (4), 242-244, 2018
142018
The tuberculosis vaccines pipeline: A new path to the same destination
M Frick
2015 PIPELINE REPORT, 163, 2015
132015
The 1/4/6x24 campaign to cure tuberculosis quickly
L McKenna, M Frick, K Angami, V Dubula, J Furin, M Harrington, ...
Nature Medicine 29 (1), 16-17, 2023
122023
Fighting TB stigma: we need to apply lessons learnt from HIV activism. BMJ Glob Health. 2017; 2 (4): e000515
A Daftary, M Frick, N Venkatesan, M Pai
Epub 2017/12/12. https://doi. org/10.1136/bmjgh-2017-000515 PMID: 29225954, 0
12
The system can't perform the operation now. Try again later.
Articles 1–20